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ABSTRACT  
Cancer has now become a common disease affecting human health. Existing cancer treatment drugs can no longer meet the growing needs of 
cancer patients, and the emergence of anticancer drug resistance has exacerbated this phenomenon. By designing and synthesizi ng new 
anticancer peptide nanoparticles and studying their anticancer effects, new strategies for cancer treatment may be obtained. Novel anticancer 
peptides are synthesized by adding basic amino acids and solid-phase synthesis technology, and their structural information is determined by 
mass spectrometry. Nanoparticles of anticancer peptide were synthesized by nano-self-assembly technology. Two novel anticancer peptides 
exhibited anticancer activity, one of which was assembled into nanoparticles.  The theoretical isoelectric points of the modified SZG3 and SZG5 
are all greater than physiological pH, and will be positively charged under physiological conditions. The estimated half -life of SZG3 and SZG5 
is significantly extended (30h), which is beneficial to increase the efficacy and reduce toxic and si de effects. SZG3 and SZG5 have a good 
inhibitory effect on tumor cells and have low toxicity to normal cells.  
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INTRODUCTION 
The morbidity and mortality of cancer are increasing rapidly 
around the world, which is related to the aging population, 
population growth and the distribution of the main risk 
factors for cancer, and partly to the social and economic 
development. Lung cancer is the most common diagnosis of 
cancer (11.6% of the total) and the leading cause of cancer 
death (18.4% of the total cancer deaths), followed by female 
breast cancer (11.6%) and prostate cancer (7.1% ) (1).  
Cancer treatment methods mainly include surgical treatment, 
radiotherapy, chemotherapy and molecular targeted therapy, 
but in the course of treatment, cancer patients have 
developed certain resistance to certain drugs. Mechanisms of 
drug resistance include drug inactivation, drug target 
changes, drug outflow, DNA damage repair, and cell death 
inhibition(2). Therefore, the development of new anticancer 
drugs is needed to solve the problems caused by the 
increase in cancer incidence and the emergence of drug 
resistance. 
Antimicrobial peptides are a class of peptide active 
substances produced by animals, plants and microorganisms 
against external pathogens(3-6). As people continue to study 
antimicrobial peptides, it is found that some of the cationic 
antimicrobial peptides have anticancer activity and show a 
strong killing effect on a variety of tumor cells(7-10). 
Compared with normal cells, there are more negatively 
charged molecules on the surface of tumor cells, such as 
sialic acid(11), etc. The cationic antimicrobial peptides 
generally have an amphiphilic structure: they are both 
hydrophilic and lipophilic(12), where lipophilicity binds them 
to cell membrane lipids, and the hydrophilic nature of 
cations causes them to interact with water or negatively 
charged residues. Based on this combination, this 
amphiphilic structure allows it to bind to the surface of 
tumor cells with negative charges on the surface, which lays 
the foundation for its interaction with tumor cell 
membranes and selectivity. In this study, anticancer peptides 
were obtained using solid-phase synthesis technology, and 
their anti-tumor activity was measured, and then the nano 
self-assembly study was conducted. 
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MATERIALS AND METHODS 
Materials 
Cell lines 
Human cervical cancer HeLa and human embryonic kidney 
293T cells are all derived from the State Key Laboratory of 
Pharmaceutical Biotechnology of Nanjing University. 
Reagents and equipment 
MTT (Shanghai Aladdin Biochemical Technology Co., Ltd.), 
DMSO (J&K Scientific Ltd.), fetal bovine serum (WISENT Inc), 
multifunctional microplate reader (Tecan M200 PRO), 
nano-potential particle size analyzer ( Malvern Nano-ZS), 
DMEM (Vicent Biotech Co., Ltd.), CO2 cell incubator 
(Thermo Forma). 
Novel anticancer peptides SZG3 and SZG5 
The SZG3 sequence is MAMVGTRHHHHH with a purity of 
95.938%; the SZG5 sequence is MWAIVLLRHHHHH with a 
purity of 97.298%, all synthesized by Hefei Guo peptide 
Biotechnology Co., Ltd. through solid-phase synthesis 
technology. 
Method 
Design of novel anticancer peptides
 
 
Figure 1 Design strategy of new anticancer peptides 
 
 
Two anticancer peptides AP01519 and AP02372 with 
anti-tumor activity were screened in the Antimicrobial 
Peptide Database (APD); adding the basic amino acid 
arginine to the C-terminal end of the above two amino acids 
resulted in stronger tumor specificity Cationic peptide; 
adding 5 histidines to the C segment makes the whole 
peptide chain more cationic; adding methionine to the 
N-terminus makes it have the potential for bacterial 
expression. ProtParam was used to analyze the basic 
parameters of the new anticancer peptides. 
MTT experiment and apoptosis experiment  
MTT experiment: Hela cells and 293T cells in logarithmic 
growth phase were used, and the cell concentration was 
adjusted to 5×104 Cells/mL with culture medium containing 
10% fetal bovine serum, and distributed into 96-well plates. 
After 12 hours of incubation, different concentrations of 
peptides were added and a blank control was set. The 
absorbance at 490 nm wavelength was measured by MTT 
method. Apoptosis experiment: Hela cells in logarithmic 
growth phase were used, and the cell concentration was 
adjusted to 5×104 Cells/mL with culture medium containing 
10% fetal bovine serum. After 12 hours of incubation, 
different concentrations of peptides were added and a blank 
control was set. Annexin V-FITC/PI double staining 
apoptosis detection method was used to detect the 
apoptosis process. 
Anticancer peptide nanoparticle self-assembly experiment 
Take 10 mg of the synthesized amphiphilic anticancer 
peptide and dissolve it in PBS buffer (pH 7.4). At a constant 
temperature of 37°C, the anticancer peptide was suspended 
by ultrasound for 15 min and 30 min, respectively. The 
ultrasonically treated amphiphilic anticancer peptides were 
placed in a constant temperature incubator, incubated at 
37°C for 35 min, and then taken out to observe the 
self-assembly of amphiphilic anticancer peptides. The 
nano-self-assembly was preliminarily observed with a 
nano-potential particle size analyzer, and the 
microstructure formed after anticancer peptide 
self-assembly was observed with a transmission electron 
microscope(TEM). 
TEM imaging experiment 
The sample was negatively stained with 5% 
phosphotungstic acid, dried and tested with a transmission 
electron microscope (JEM-2100), with a voltage of 200 KV 
and an electron beam current of 102 µA.
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RESULT AND DISCUSSION  
Mass spectrum of novel anticancer peptides 
 
Figure 2 Mass spectrum of SZG3 
The mass spectrum of SZG3 is shown in Figure 2, with theoretical value of 1450.67 and observed value of 1450.62. 
 
Figure 3 Mass spectrum of SZG5 
The mass spectrum of SZG5 is shown in the figure above, the theoretical value is 1850.08, and the observed value is 1849.98. 
Analysis of the basic properties of new anticancer peptides 
Table.1 Basic properties of new anticancer peptides 
Name Sequence Theoretical 
pI 
Grand average 
of 
hydropathicity 
(GRAVY) 
Instability 
index 
Aliphatic 
index 
Estimated 
half-life(h) 
AP01519 AMVGT 5.57 1.360 -25.96 78.00 4.4 
SZG3 MAMVGTRHHHHH 9.59 -0.983 21.35 32.50 30 
AP02372 WAIVLL 5.52 2.867 -30.87 260.00 2.8 
SZG5 MWAIVLLRHHHHH 9.59 -0.108 20.77 120 30 
   
The theoretical isoelectric point (pI) of AP01519 and 
AP02372 are less than the physiological pH, and will be 
negatively charged under the physiological conditions; the 
theoretical isoelectric points of SZG3 and SZG5 after 
modification are both greater than the physiological pH, 
and will be positively charged under the physiological 
conditions. The GRAVY of AP01519 and AP02372 were 
higher than 1, indicating that they did not have good 
hydrophilicity; the GRAVY of SZG3 and SZG5 after 
modification were lower than 1, indicating that the two 
anticancer peptides had good hydrophilicity. All of the four 
anticancer peptides have a certain degree of liposolubility, 
and the modified SZG3 and SZG5 have decreased 
liposolubility and increased amphiphilicity. The instability 
indexes are all less than 30, so they can be considered stable. 
The estimated half lives of AP01519 and AP02372 were less 
than 5h, indicating that repeated administration was needed 
to reach the steady-state concentration, and it would 
increase the toxicity and side effects to the body; while the 
estimated half lives of SZG3 and SZG5 were significantly 
prolonged (30h), which was beneficial to increase the 
efficacy and reduce the toxicity and side effects.
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Tumor cell inhibition and cytotoxicity experiment 
  Table.2 Tumor suppressive activity and cytotoxicity of novel anticancer peptides 
 IC50(μM)-Hela IC50(μM)-293T 
SZG3 68.54 ＞100 
SZG5 68.73 ＞100 
 
As shown in Table 2, the IC50 values of SZG3 and SZG5 to HeLa cells are 68.54 μM and 68.73 μM respectively, while the toxicity 
to 293T cells is relatively low. This indicates that SZG3 and SZG5 have good inhibitory effects on tumor cells. 
 
Figure 4 Apoptosis effect of SZG3 on Hela cells 
It can be seen from Fig. 4 that after incubation for 24 h, SZG3 has apoptosis inducing effect on HeLa cells at a lower 
concentration, but higher concentration is required to achieve obvious apoptosis effect. 
Nano self-assembly of SZG3 
 
Figure 5 Distribution of SZG3 self-assembled nanoparticles after 15 min ultrasound 
After 15 minutes of ultrasound, SZG3 was self-assembled into nanoparticles of different sizes at 37 ℃. It can be seen from Figure 
5 that nanoparticles are mainly distributed between 30-60 nm. 
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As shown in Figure 6, after 30 minutes of ultrasound, the size 
of 40.4% of SZG3 nanoparticles is 78.82 nm, and that of 
59.6% is 91.28 nm. This shows that the ultrasonic time 
affects the formation of different sizes of SZG3 nanoparticles.
 
 
Figure 6 Distribution of SZG3 self-assembled nanoparticles after 30 min ultrasound 
 
Compared with SZG3, SZG5 does not self assemble into 
nanoparticles, which may be due to its high liposolubility. This 
shows that the appropriate liposolubility is very important in 
the formation of nanoparticles. 
 
Figure 7 Imaging diagram of SZG3 self-assembled 
nanoparticles after 30 min ultrasound 
As shown in Figure 7, SZG3 is self-assembled into 
nanoparticles of about 90 nm, which has potential tumor 
targeting properties. 
 
 
CONCLUSION 
Cancer kills millions of people around the world every year, 
but so far there is no effective way to cure cancer. In recent 
years, researchers have made a lot of achievements in 
cancer chemotherapy, which improves the sensitivity of 
chemotherapy drugs to cells and reduces the side effects of 
drugs. However, the cure rate of surgery and radiotherapy 
and chemotherapy did not reach a high level. As cancer is a 
chronic disease, the number of gene mutations increases 
with the growth of people's age. However, after 
radiotherapy, chemotherapy and surgery, the human body 
can not completely eliminate all cancer cells, resulting in a 
high recurrence rate of cancer. Through the modification of 
antibacterial peptide, it has stronger cationic property and 
better targeting property; through the nano self-assembly 
experiment, SZG3 nanoparticles are obtained, which has 
stronger theoretical targeting property. Because of the 
enhanced permeability and retention (EPR) effect of 
nanoparticles, SZG3 nanoparticles can enter the blood 
vessels of tumor tissue better in theory by intravenous 
injection. This provides a strategy for the development of 
anticancer peptide nanoparticles with higher activity in the 
future. 
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